InSnip

Story one of ten today, about five minutes for the lot

A campus view of a multi-storey pale-pink and red research building behind a modern two-storey grey structure with curved decorative panels and green glazing, fronted by a grassed
✓ PerthNowScience & Systems

Australian trial offers hope to 1 in 70 Australians with coeliac

The Walter and Eliza Hall Institute is recruiting volunteers for a phase two trial of a drug that stops the immune response to gluten.

Why it mattersCoeliac disease is chronic and requires strict diet control. A drug that blocks the immune response could let sufferers eat normally again and greatly improve quality of life.

AustraliaOne in 70 Australians have coeliac disease, though only 20 per cent are diagnosed. This Australian-led breakthrough could transform life for hundreds of thousands of people, especially those unaware they have the condition.

Corroborated bythenightly.com.au

✓ Claims checked against the source. checked 35 min ago

Next in today's edition

That is three stories, about two minutes.

A sitting is ten stories, about five minutes, and then you are done for the day.

Read the other seven →

Free, no app needed. Australian news, every claim sourced.

Tomorrow's edition, 7am

The day's stories in one free email. No noise, unsubscribe anytime.

One email a day. Pure signal, no noise.

Know someone who should read this?

Prefer an app? It is free.

Download on the App StoreGet it on Google Play

InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.

More Science & Systems on InSnip →

Today's Daily Brief: ten stories in five minutes →

Open this story in the reader →

Seven more todayFree, about five minutes Read →